This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stagno, S Articles by O'Beirne, A J Search for Related Content PubMed PubMed Citation Articles by Stagno, S Articles by O'Beirne, A J

 Previous Article  |  Next Article 

J Clin Microbiol. 1985 June; 21(6): 930-935

Immunoglobulin M antibodies detected by enzyme-linked immunosorbent assay and radioimmunoassay in the diagnosis of cytomegalovirus infections in pregnant women and newborn infants.

ABSTRACT

Immunoglobulin M (IgM) antibodies were detected by a commercially available enzyme-Linked Immunosorbent Assay (ELISA) in 36 of 49 (73%) pregnant women with primary cytomegalovirus (CMV) infection. A positive ELISA-IgM result occurred in 10 of 13 patients (77%) assessed within 8 weeks of seroconversion. The sensitivity of the radioimmunoassay (RIA) to identify primary infection in pregnant women was comparable, 78% in general and 86% for women tested within 16 weeks of seroconversion. Of the 36 women with primary infection who had detectable IgM antibodies by ELISA, 25 (69%) were delivered of congenitally infected infants, whereas of the 13 with undetectable IgM antibodies, 7 (54%) transmitted the infection in utero. IgM antibodies were detected by ELISA in only 5 of 43 (11%) women who experienced a recurrence of CMV which either did or did not result in congenital infection. RIA was less likely to measure CMV-specific IgM in recurrent infection, inasmuch as 1 of 19 (5.2%) women with proven recurrent infection had detectable IgM antibody, giving RIA a better specificity for primary infection. Specific IgM antibodies were detected by ELISA in 42 of 61 (69%) babies congenitally infected with CMV and in 4 of 70 (5.7%) uninfected control newborn infants. The RIA was superior for diagnosis of congenital CMV infection, with a sensitivity of 89% and a specificity of 100%. The lower sensitivity of the ELISA-IgM occurred in the category of congenitally infected infants born to mothers with recurrent infection (43%), a group that is at the lowest risk of disease or to develop sequelae. This commercially available ELISA-IgM could be used in combination with a CMV-specific IgG test for monitoring women during pregnancy for primary infection.

This article has been cited by other articles:

• Revello, M. G., Gerna, G. (2002). Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant. Clin. Microbiol. Rev. 15: 680-715 [Abstract] [Full Text]  
• Lang, D., Vornhagen, R., Rothe, M., Hinderer, W., Sonneborn, H.-H., Plachter, B. (2001). Cross-Reactivity of Epstein-Barr Virus-Specific Immunoglobulin M Antibodies with Cytomegalovirus Antigens Containing Glycine Homopolymers. CVI 8: 747-756 [Abstract] [Full Text]  
• Lazzarotto, T., Galli, C., Pulvirenti, R., Rescaldani, R., Vezzo, R., La Gioia, A., Martinelli, C., La Rocca, S., Agresti, G., Grillner, L., Nordin, M., van Ranst, M., Combs, B., Maine, G. T., Landini, M. P. (2001). Evaluation of the Abbott AxSYM Cytomegalovirus (CMV) Immunoglobulin M (IgM) Assay in Conjunction with Other CMV IgM Tests and a CMV IgG Avidity Assay. CVI 8: 196-198 [Abstract] [Full Text]  
• Demmler, G. J., Istas, A., Easley, K. A., Kovacs, A., the Pediatric Pulmonary and Cardiovascular Complic, (2000). Results of a Quality Assurance Program for Detection of Cytomegalovirus Infection in the Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Infection Study. J. Clin. Microbiol. 38: 3942-3945 [Abstract] [Full Text]  
• Mustakangas, P., Sarna, S., Ammala, P., Muttilainen, M., Koskela, P., Koskiniemi, M. (2000). Human cytomegalovirus seroprevalence in three socioeconomically different urban areas during the first trimester: a population-based cohort study. Int J Epidemiol 29: 587-591 [Abstract] [Full Text]  
• Maine, G. T., Stricker, R., Schuler, M., Spesard, J., Brojanac, S., Iriarte, B., Herwig, K., Gramins, T., Combs, B., Wise, J., Simmons, H., Gram, T., Lonze, J., Ruzicki, D., Byrne, B., Clifton, J. D., Chovan, L. E., Wachta, D., Holas, C., Wang, D., Wilson, T., Tomazic-Allen, S., Clements, M. A., Wright, G. L. Jr., Lazzarotto, T., Ripalti, A., Landini, M. P. (2000). Development and Clinical Evaluation of a Recombinant-Antigen-Based Cytomegalovirus Immunoglobulin M Automated Immunoassay Using the Abbott AxSYM Analyzer. J. Clin. Microbiol. 38: 1476-1481 [Abstract] [Full Text]  
• Boppana, S. B., Fowler, K. B., Britt, W. J., Stagno, S., Pass, R. F. (1999). Symptomatic Congenital Cytomegalovirus Infection in Infants Born to Mothers With Preexisting Immunity to Cytomegalovirus. Pediatrics 104: 55-60 [Abstract] [Full Text]  
• Lazzarotto, T., Ripalti, A., Bergamini, G., Battista, M. C., Spezzacatena, P., Campanini, F., Pradelli, P., Varani, S., Gabrielli, L., Maine, G. T., Landini, M. P. (1998). Development of a New Cytomegalovirus (CMV) Immunoglobulin M (IgM) Immunoblot for Detection of CMV-Specific IgM. J. Clin. Microbiol. 36: 3337-3341 [Abstract] [Full Text]  
• Morris, D. J., Appleton, A. L., Sviland, L., Schmidt, C.A., Wilborn, F.F., Siegert, W., Cone, R., Corey, L., Hackman, R., Akashi, K., Eizuru, Y., Sumiyoshi, Y. (1993). Primary Human Herpesvirus 6 Infection in an Adult. NEJM 329: 1817-1819 [Full Text]